Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Cash & Current Investments (2018 - 2025)

Quantum Biopharma's Cash & Current Investments history spans 8 years, with the latest figure at $2.4 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 67.15% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.4 million, a 67.15% decrease, with the full-year FY2025 number at $2.4 million, down 67.15% from a year prior.
  • Cash & Current Investments hit $2.4 million in Q4 2025 for Quantum Biopharma, down from $5.5 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for QNTM hit a ceiling of $40.8 million in Q3 2021 and a floor of $2.4 million in Q4 2025.
  • Historically, Cash & Current Investments has averaged $15.8 million across 5 years, with a median of $7.2 million in 2024.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 245.78% in 2021 and later crashed 87.6% in 2023.
  • Tracing QNTM's Cash & Current Investments over 5 years: stood at $35.4 million in 2021, then tumbled by 52.06% to $17.0 million in 2022, then crashed by 74.24% to $4.4 million in 2023, then soared by 64.59% to $7.2 million in 2024, then crashed by 67.15% to $2.4 million in 2025.
  • Business Quant data shows Cash & Current Investments for QNTM at $2.4 million in Q4 2025, $5.5 million in Q3 2025, and $6.0 million in Q2 2025.